How does it work?

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disease that affects the nerves. Patients with CIDP and multifocal motor neuropathy (MMN) often require expensive medication as maintenance treatment, which must be tailor-made and individual-dependent in terms of dosage and type. During the first year of treatment, patients frequently visit the clinic to monitor the effectiveness of the medication and adjust it as necessary. However, home monitoring can be used to adjust medication more precisely by leveraging additional health data, reducing the need for hospital visits. By providing a stronger foundation for guiding treatment, home monitoring reduces the number of outpatient visits required.